Irkec, C. Et Al. 2018. The link between epigenetic regulators, neurotrophins and treatment efficacy in patients with multiple sclerosis. 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , (Berlin, Germany), 893.

Irkec, C., Ozdemir, F. Y., Altiparmak, T., Tural, R., Altan, N., & Soke, F., (2018). The link between epigenetic regulators, neurotrophins and treatment efficacy in patients with multiple sclerosis . 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) (pp.893). Berlin, Germany

Irkec, C. Et Al. "The link between epigenetic regulators, neurotrophins and treatment efficacy in patients with multiple sclerosis," 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Germany, 2018

Irkec, C. Et Al. "The link between epigenetic regulators, neurotrophins and treatment efficacy in patients with multiple sclerosis." 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , Berlin, Germany, pp.893, 2018

Irkec, C. Et Al. (2018) . "The link between epigenetic regulators, neurotrophins and treatment efficacy in patients with multiple sclerosis." 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , Berlin, Germany, p.893.

@conferencepaper{conferencepaper, author={C. Irkec Et Al. }, title={The link between epigenetic regulators, neurotrophins and treatment efficacy in patients with multiple sclerosis}, congress name={34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)}, city={Berlin}, country={Germany}, year={2018}, pages={893} }